Table 1.
Transcription factor | Nucleotide position | Matrix simulation score | Sequence |
---|---|---|---|
Ets—family member ELF-2 (NERF1a) | 10–26 | 0.910 | cgaggaGGAAgaggttg |
Human zinc finger protein ZNF35 | 12–24 | 0.963 | aggaggAAGAggt |
b zip family, induced by ER damage binds in association with NF-Y | 67–81 | 0.945 | ccgCCACggccggcc |
STAT6: signal transducer and activator of transcription 6 | 107–125 | 0.963 | gcgaaTTCCcgagaactcg |
Ikaros 1, potential regulator of lymphocyte differentiation | 112–124 | 0.934 | tctcGGGAattcg |
HMGI (Y) high-mobility group protein I (Y) factor | 113–125 | 0.953 | gcgAATTcccgag |
PAX6 paired domain and homeodomain | 172–190 | 0.900 | ggcttgggcCCAGgcccgg |
Myc-associated zinc finger protein (MAZ) | 188–200 | 0.910 | gtgcGAGGggccg |
Gut-enriched Krueppel-like factor | 203–217 | 0.924 | agaaaaggtaAGGGc |
c-Rel | 264–278 | 0.914 | aaaggaacTTCCccc |
NF-kappaB | 264–278 | 0.964 | ggGGGAagttccttt |
Zinc finger transcription factor ZBP-89 | 270–292 | 0.971 | acttcccccaCCCCctcgggtgc |
Erythroid Krueppel like factor (EKLF) | 277–289 | 0.915 | cccgaggGGGTgg |
Myeloid zinc finger protein MZF1 | 327–333 | 0.985 | gcGGGGa |
Nuclear factor of activated T cells | 368–378 | 0.975 | cgagGAAAacc |
Brn-2, POU-III protein class | 391–403 | 0.946 | cggccattttTAATtcttt |
mRNA nucleotide sequence for p300 (NM_001429) obtained from NCBI Web-based resource (http://www.ncbi.nlm.nih.gov/). Preceding from the predicted start site of p300 mRNA, 403 nucleotide sequences were analyzed using commercially available software (Genomatix: http://www.genomatix.de/) to analyze and predict transcription factor binding sites in the promoter region in the p300 gene (chromosome 22, contig-NT_01150.09, Homo sapiens chromosome 22). Base pairs in capital letters denote the core sequence used by MatInspector (Genomatix). Matrix simulation scores with great than 0.90 were selected from 66 total predicted transcription factor binding sites, based from a 1.00 core simulation score of known nucleotide sequence binding sites.